Milpro 4 mg/10 mg Film-coated Tablets for Small Cats and Kittens

It is recommended to treat all the animals living in the same household
concomitantly.
In order to develop an effective worm control programme local epidemiological
information and the living conditions of the cat should be taken into account and
therefore it is recommended to seek professional advice.
Parasite resistance to any particular class of anthelmintic may develop following
frequent, repeated use of an anthelmintic of that class.
When D. caninum infection is present, concomitant treatment against intermediate
hosts, such as fleas and lice, should be considered to prevent re-infection.

No studies have been performed with severely debilitated cats or individuals with
seriously compromised kidney or liver function. The product is not recommended for
such animals or only according to a benefit/risk assessment by the responsible
veterinarian.
Studies have shown that treatment of dogs with a high number of circulating
microfilariae can sometimes lead to the appearance of hypersensitivity reactions,
such as pale mucous membranes, vomiting, trembling, laboured breathing or
excessive salivation. These reactions are associated with the release of proteins
from dead or dying microfilariae and are not a direct toxic effect of the product. The
use in dogs suffering from microfilaremia is thus not recommended. In the absence
of data on cats with microfilaraemia, its use should be according to a benefit risk
assessment by the attending veterinarian.
As the tablets are flavoured, they should be stored in a safe place out of the reach of
animals.
As per good veterinary practice, animals should be weighed to ensure accurate
dosing.
Ensure cats and kittens weighing between 0.5 kg and ≤2 kg receive the appropriate
tablet strength (4 mg MBO/10 mg praziquantel) and the appropriate dose (1/2 or 1
tablet) for the corresponding weight band (1/2 tablet for cats weighing 0.5 to 1 kg ; 1
tablet for cats weighing >1 to 2 kg – 1 tablet).
4.5 ii Special precautions to be taken by the person administering the veterinary
medicinal product to animals
Wash hands after use.
Part tablets should be returned to the open blister pack and stored in the carton.
In the event of accidental ingestion of the tablets, particularly by a child, seek medical
advice immediately and show the package leaflet or the label to the doctor.

Revised: November 2025
MA split from NI MA following AN: 03461/2024
4.5 iii Other precautions
Echinococcosis represents a hazard for humans. As Echinococcosis is a notifiable
disease to the World Organisation for Animal Health (OIE), specific guidelines on the
treatment and follow-up, and on the safeguard of persons, need to be obtained from
the relevant competent authority.